These products include reagents, kits, and analytical instruments used to study cancer cell biology, proliferation, migration, and interactions. Cancer remains one of the leading causes of death worldwide, driving significant research efforts and demand for products used in cancer cell analysis.
The global Cancer Cell Market is estimated to be valued at US$ 10799.45 Mn or Bn in 2023 and is expected to exhibit a CAGR of 8.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the Global Cancer Cell Market Size is the rise of artificial intelligence applications. AI is allowing researchers to analyze huge amounts of molecular and cellular data from cancer samples to identify patterns and discover new targets. AI tools are being integrated into analytical instruments to automate cancer cell analysis workflows and accelerate research. Deep learning algorithms are also being trained on large cancer cell datasets to assist in drug discovery and precision medicine efforts. As AI capabilities continue advancing, it is expected to transform various areas of cancer research relying on cancer cell analysis over the coming years.
Segment Analysis
The cancer cell market is segmented into cell type, application, technique, and end-user. Based on cell type, the market is segmented into leukemia, lymphoma, breast cancer, lung cancer, colorectal cancer, prostate cancer, ovarian cancer, melanoma, and others. The lung cancer cell segment held the largest market share in 2023 owing to the increasing prevalence of lung cancer worldwide.
Key Takeaways
The global cancer cell market is expected to witness high growth, exhibiting CAGR of 8.9% over the forecast period, due to increasing geriatric population and rising incidence of cancer globally.
Regional analysis
North America dominated the global cancer cell market in 2023 and is projected to maintain its dominance during the forecast period. This is attributed to the presence of major players in the region and government support for research activities. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to growing healthcare spending and rising awareness about cancer screening.
Key players
Key players operating in the cancer cell market are Abbott Laboratories, Novartis International AG, Arcellx, Autolus Therapeutics, Kite Pharma, Cellectis, Celyad Oncology, Crescendo Biologics Limited, GammaDelta Therapeutics Ltd., Bio-Rad Laboratories Inc, QIAGEN Inc, Thermo Fisher Scientific, Merck Millipore, Siemens Healthineers AG, and GE Healthcare. Abbott Laboratories held the highest market share in 2023 owing to its robust product offerings in the cancer cell market.
For More Insights, Read- https://www.newsstatix.com/cancer-cell-market-size-share-analysis-2023-2030/
Comments
0 comment